ClinicalTrials.gg
Sign In

Vaginosis, Bacterial clinical trials

The registry lists 240 studies for Vaginosis, Bacterial across more than 10 countries. 39 are recruiting or about to start. 205 of them are mainly about Vaginosis, Bacterial (how this is decided). Per ClinicalTrials.gov, last updated 2026-10-26.

Get an email when these change. Save the Vaginosis, Bacterial studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.

Watch these studies
See an example email

Example · made-up studies

Breast cancer · Recruiting: 2 came in, 3 changed

What changed in your saved searches, Oct 31 – Nov 6:

A study of drug A after surgery for early breast cancer

Came in · now Recruiting

Drug B with hormone therapy in advanced breast cancer

Changed

· Sites: 4 added, including Seoul and Busan

· Enrollment: 300 → 450 participants

Exercise during chemotherapy

Now Active, not recruiting

One email a week for all your saved searches. Stop any time.

Status

Completed
150
Status unknown
26
Recruiting
23
Terminated
14
Not yet recruiting
14
Active, not recruiting
6

Phase

Phase 2
40
Phase 3
40
Phase 4
34
Phase 1
24
Early Phase 1
10

Where

United States
82
China
16
Canada
9
Israel
8
Brazil
7
Sweden
7

Who runs them

National Institute of Allergy and Infectious Diseases (NIAID) (8) · Starpharma Pty Ltd (6) · University of Pittsburgh (5) · Skaraborg Hospital (4) · Vaginal Biome Science (4) · University of Alabama at Birmingham (4) · Gedea Biotech AB (4) · Peter Humaidan (3)

What is being tested here

Drugs under test in Vaginosis, Bacterial studies, those with the most open studies first. Medicines only given beside them are not counted. How drugs are counted

DrugOpenPhase 3All
Metronidazole2421
Clindamycin116
Secnidazole125
Azithromycin123
Ceftriaxone111
Clotrimazole111
Doxycycline111
Lactobacillus acidophilus/Estriol Vaginal Tablet101
Astodrimer046
Tinidazole015

Drug classes tested here Hormonal contraceptives 4

Coming up

3phase 3 studies under way
20studies finish main data collection within a year1 of them phase 3

Studies recruiting or running, from their records. “Main data collection” ends at the primary completion date, the sponsor’s own estimate, which often moves.

The 10 nearest, phase 3 first

Who these studies take

Of the 23 Vaginosis, Bacterial studies recruiting now, 7 (30%) set no upper age limit and 16 (70%) stop at 75 or younger. 2 (9%) take children under 18. 21 (91%) are for women only and 1 (4%) for men only; 9 (39%) take healthy volunteers.

Recruiting studies that take each age, of 23
AgeWomenMen
101 (4%)0 (0%)
1820 (87%)2 (9%)
3022 (96%)2 (9%)
4022 (96%)2 (9%)
5016 (70%)2 (9%)
659 (39%)2 (9%)
757 (30%)2 (9%)
856 (26%)2 (9%)

Across all 240 studies, recruiting or not: 68% stop at 75 or younger and 67% at 65; 13% take children; 98% are for women only and <1% for men only; 35% take healthy volunteers. From each study’s registry entry; the criteria on its page decide.

How long Vaginosis, Bacterial studies take

Of 17 phase 4 interventional studies under Vaginosis, Bacterial, half reached primary completion within 23 months of starting, counting those still running.

Start to primary completionEvery sponsorIndustryNon-industry
Phase 226 mo19–41 · 14 studies——
Phase 39 mo5–25 · 12 studies——
Phase 423 mo13–41 · 17 studies——
Interventional, no phase12 mo5–56 · 52 studies——

Each figure is the month by which half the studies had reached primary completion, with the range in which the middle half did. Studies still running count until their last registry update; studies that stopped early are left out. Phase 1 includes early phase 1; observational means prospective or not stated, as retrospective and cross-sectional studies date a window of data rather than a study. How these figures are worked out

What changed recently

From the registry's own updates since Oct 14, 2026.

Started recruiting1

Newly registered4

Studies

Recruiting first, then most recently updated. Showing 50 of 240. Browse all 240 → or search them.